Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy HOOKIPA Pharma (HOOK) stocks in Canada
Learn how to easily invest in HOOKIPA Pharma stocks.
HOOKIPA Pharma is a biotechnology business based in the US. HOOKIPA Pharma stocks (HOOK.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8.67 – a decrease of 17.05% over the previous week. HOOKIPA Pharma employs 109 staff and has a trailing 12-month revenue of around $19.7 million.
How to buy shares in HOOKIPA Pharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HOOK – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in HOOKIPA Pharma?
- Has coronavirus impacted HOOKIPA Pharma shares?
- HOOKIPA Pharma shares summary
- Compare share dealing platforms
- Is HOOKIPA Pharma stock a buy or sell?
- HOOKIPA Pharma performance over time
- HOOKIPA Pharma's financials
- How volatile are HOOKIPA Pharma shares?
- Does HOOKIPA Pharma pay a dividend?
- Other common questions
HOOKIPA Pharma stock price (NASDAQ:HOOK)Use our graph to track the performance of HOOK stocks over time.
HOOKIPA Pharma shares at a glance
|Latest market close||$1.46|
|52-week range||$1.34 - $20.00|
|50-day moving average||$2.74|
|200-day moving average||$7.55|
|Wall St. target price||$9.94|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.13|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy HOOKIPA Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
HOOKIPA Pharma price performance over time
|1 week (2022-01-20)||-17.05%|
|1 month (2021-12-28)||-39.17%|
|3 months (2021-10-28)||-70.45%|
|6 months (2021-07-28)||-82.35%|
|1 year (2021-01-28)||-86.28%|
|2 years (2020-01-27)||-88.77%|
|3 years (2019-01-24)||N/A|
|5 years (2017-01-24)||N/A|
HOOKIPA Pharma financials
|Revenue TTM||$19.7 million|
|Gross profit TTM||$-35,203,000|
|Return on assets TTM||-35.5%|
|Return on equity TTM||-66.82%|
|Market capitalisation||$45.8 million|
TTM: trailing 12 months
HOOKIPA Pharma share dividends
We're not expecting HOOKIPA Pharma to pay a dividend over the next 12 months.
HOOKIPA Pharma share price volatility
Over the last 12 months, HOOKIPA Pharma's shares have ranged in value from as little as $1.34 up to $20. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HOOKIPA Pharma's is 1.0046. This would suggest that HOOKIPA Pharma's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
HOOKIPA Pharma overview
HOOKIPA Pharma Inc. , a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc.
Stocks similar to HOOKIPA Pharma
HOOKIPA Pharma in the news
Ackman takes a big stake in Netflix, excited about company's long-term prospects
What to watch today: Stock futures turn positive, reversing big overnight losses
5 things to know before the stock market opens Thursday
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Nauticus Robotics, Inc. (KITT) stock in Canada when it goes public
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Bitcoin Private (BTCP) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Bitcoin Private, lists some exchanges where you can get it and provides daily price data on BTCP.
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.